[Federal Register Volume 75, Number 36 (Wednesday, February 24, 2010)]
[Notices]
[Page 8369]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-3585]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Recombinant DNA Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Recombinant DNA Advisory Committee.
    Date: March 10-11, 2010.
    Time: March 10, 2010, 8 a.m. to 5:30 p.m.
    Agenda: The Recombinant DNA Advisory Committee will review and 
discuss selected human gene transfer protocols as well as related 
data management activities. Additionally there will be a discussion 
of a proposal to exempt the mating of certain biosafety level 1 
transgenic rodents from the requirements of Section III-E-3 of the 
NIH Guidelines for Research with Recombinant DNA Molecules. Please 
check the meeting agenda at http://oba.od.nih.gov/rdna_rac/rac_meetings.html for more information.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Time: March 11, 2010, 8 a.m. to 1:30 p.m.
    Agenda: The Recombinant DNA Advisory Committee will review and 
discuss selected human gene transfer protocols as well as related 
data management activities. There will also be a discussion of the 
University of Wisconsin's application requesting a determination of 
the appropriate biocontainment for the cloning of Ebola and Marburg 
cDNAs into E. coli. Please check the meeting agenda at http://oba.od.nih.gov/rdna_rac/rac_meetings.html for more information.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Laurie Lewallen, Advisory Committee Coordinator, 
Office of Biotechnology Activities, National Institutes of Health, 
6705 Rockledge Drive, Room 750, Bethesda, MD 20892-7985, 301-496-
9838, <a href="/cdn-cgi/l/email-protection#54383123353838313a38143b307a3a3d3c7a333b22"><span class="__cf_email__" data-cfemail="9df1f8eafcf1f1f8f3f1ddf2f9b3f3f4f5b3faf2eb">[email protected]</span></a>.
    Information is also available on the Institute's/Center's home 
page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and any 
additional information for the meeting will be posted when 
available. OMB's ``Mandatory Information Requirements for Federal 
Assistance Program Announcements'' (45 FR 39592, June 11, 1980) 
requires a statement concerning the official government programs 
contained in the Catalog of Federal Domestic Assistance. Normally 
NIH lists in its announcements the number and title of affected 
individual programs for the guidance of the public. Because the 
guidance in this notice covers virtually every NIH and Federal 
research program in which DNA recombinant molecule techniques could 
be used, it has been determined not to be cost effective or in the 
public interest to attempt to list these programs. Such a list would 
likely require several additional pages. In addition, NIH could not 
be certain that every Federal program would be included as many 
Federal agencies, as well as private organizations, both national 
and international, have elected to follow the NIH Guidelines. In 
lieu of the individual program listing, NIH invites readers to 
direct questions to the information address above about whether 
individual programs listed in the Catalog of Federal Domestic 
Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)


    Dated: February 17, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-3585 Filed 2-23-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>